MARIO
FERNANDEZ FRAGA
Profesor Asociado
Ludwig Maximilian University of Munich
Múnich, AlemaniaPublicaciones en colaboración con investigadores/as de Ludwig Maximilian University of Munich (5)
2018
-
Evolutionary routes and KRAS dosage define pancreatic cancer phenotypes
Nature, Vol. 554, Núm. 7690, pp. 62-68
2013
-
A Genetic Progression Model of BrafV600E-Induced Intestinal Tumorigenesis Reveals Targets for Therapeutic Intervention
Cancer Cell, Vol. 24, Núm. 1, pp. 15-29
2009
-
Salermide, a Sirtuin inhibitor with a strong cancer-specific proapoptotic effect
Oncogene, Vol. 28, Núm. 6, pp. 781-791
2007
-
Epigenetic disruption of ribosomal RNA genes and nucleolar architecture in DNA methyltransferase 1 (Dnmt1) deficient cells
Nucleic Acids Research, Vol. 35, Núm. 7, pp. 2191-2198
2005
-
Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer
Nature Genetics, Vol. 37, Núm. 4, pp. 391-400